From the Research
Treatment for UV keratitis primarily involves removing the source of UV exposure and providing pain relief while the cornea heals, with first-line treatment including lubricating eye drops or ointments and antibiotic drops like erythromycin or ciprofloxacin to prevent secondary infection. The goal of treatment is to reduce morbidity, mortality, and improve quality of life by promoting healing and preventing complications. For pain management, oral analgesics such as acetaminophen or ibuprofen can be used, and cycloplegic drops like cyclopentolate 1% or homatropine 2% help reduce pain from ciliary muscle spasm 1.
Some key considerations in the treatment of UV keratitis include:
- Avoiding the use of topical non-steroidal anti-inflammatory drugs (NSAIDs) due to the potential risk of corneal complications, as reported in a study published in Ophthalmology in 2001 2
- Using antibiotic drops to prevent secondary infection, with fluoroquinolones and aminoglycoside-cephalosporin being effective options, as shown in a systematic review and meta-analysis published in The British Journal of Ophthalmology in 2014 3
- Providing supportive care, such as cold compresses and avoiding contact lens use until healing is complete, typically within 24-48 hours
It's worth noting that the use of topical NSAIDs for analgesia in traumatic corneal abrasions, including UV keratitis, has been evaluated in several studies, with a Cochrane review published in 2017 finding low-certainty evidence to support their use 1. However, the potential risks and benefits of topical NSAIDs should be carefully considered in each individual case.
Overall, the treatment of UV keratitis should prioritize promoting healing, preventing complications, and improving quality of life, with a focus on evidence-based practices and careful consideration of the potential risks and benefits of different treatment options.